<p><b>A</b>) Immunofluorescent co-staining of Sox2 (green) with the basal-specific marker p63 (red), showing that 75% of normal basal-epithelial cells are positive for both Sox2 and p63 (yellow) while the remaining 25% are Sox2-negative (red). DAPI staining highlights nuclei (representative images of normal prostate epithelium acquired from three different individual patient specimens). <b>B</b>) Western blotting of a series of patient-derived Prostate (PrEC) and Seminal Vesicle (SVEC) epithelial sell (PrEC) cultures demonstrates that a portion of these cultures express detectable Sox2, while other PrEC and all SVEC cultures do not. <b>C</b>) Immunocytochemical staining of Sox2 showing uniform nuclear Sox2 expression in Sox2-positive PrECs ...
Sox2 is thought to be an important regulator of self-renewal in embryonic stem cell. According to th...
<p>(B) Representative images of Sox2 immunostaining in pTRE-Sox21-eGFP samples after 12 hours of Dox...
Critical issues in prostate cancer (PC) are a. identification of molecular drivers of the highly agg...
<p><b>A</b>) Immunohistochemical staining of Sox2 demonstrating representative nuclear basal epithel...
Despite intensive study, gaps remain in our understanding of prostate epithelial stem cell specifica...
<p>(A) Photomicrographs of DU-145 prostate cancer cells infected with FUW-M2rtTA or FUW-M2rtTA and F...
<p><b>A)</b> Sox2 expression was analyzed by immunoblotting in BPH-1 or DU145 cells after transfecti...
<p>OE sections harvested from <b>E14.5</b> animals were stained for <b>SOX2</b>, <b>K18</b> and <b>H...
<p><b>A</b>) To test whether AR signaling impacted Sox2 expression, we ectopically expressed AR (LV-...
Despite advances in detection and therapy, castration-resistant prostate cancer continues to be a ma...
<p><b>A</b>) Ectopic expression of Sox2 in castrate-sensitive LAPC-4 (LV-Sox2, n = 10 mice) cells is...
Despite advances in detection and therapy, castration-resistant prostate cancer continues to be a ma...
While the survival rate is close to 100% for men who are diagnosed with local prostate cancer diseas...
<p>Microphotographs of tissue microarray cores showing normal prostate and prostate cancer tissues: ...
<p>(A) Negative nuclear SOX2 staining in a moderately differentiated CRC. (B) Positive nuclear SOX2 ...
Sox2 is thought to be an important regulator of self-renewal in embryonic stem cell. According to th...
<p>(B) Representative images of Sox2 immunostaining in pTRE-Sox21-eGFP samples after 12 hours of Dox...
Critical issues in prostate cancer (PC) are a. identification of molecular drivers of the highly agg...
<p><b>A</b>) Immunohistochemical staining of Sox2 demonstrating representative nuclear basal epithel...
Despite intensive study, gaps remain in our understanding of prostate epithelial stem cell specifica...
<p>(A) Photomicrographs of DU-145 prostate cancer cells infected with FUW-M2rtTA or FUW-M2rtTA and F...
<p><b>A)</b> Sox2 expression was analyzed by immunoblotting in BPH-1 or DU145 cells after transfecti...
<p>OE sections harvested from <b>E14.5</b> animals were stained for <b>SOX2</b>, <b>K18</b> and <b>H...
<p><b>A</b>) To test whether AR signaling impacted Sox2 expression, we ectopically expressed AR (LV-...
Despite advances in detection and therapy, castration-resistant prostate cancer continues to be a ma...
<p><b>A</b>) Ectopic expression of Sox2 in castrate-sensitive LAPC-4 (LV-Sox2, n = 10 mice) cells is...
Despite advances in detection and therapy, castration-resistant prostate cancer continues to be a ma...
While the survival rate is close to 100% for men who are diagnosed with local prostate cancer diseas...
<p>Microphotographs of tissue microarray cores showing normal prostate and prostate cancer tissues: ...
<p>(A) Negative nuclear SOX2 staining in a moderately differentiated CRC. (B) Positive nuclear SOX2 ...
Sox2 is thought to be an important regulator of self-renewal in embryonic stem cell. According to th...
<p>(B) Representative images of Sox2 immunostaining in pTRE-Sox21-eGFP samples after 12 hours of Dox...
Critical issues in prostate cancer (PC) are a. identification of molecular drivers of the highly agg...